These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 83910)

  • 1. Serum acute-phase proteins and immunoglobulins in patients with gliomas.
    Weiss JF; Morantz RA; Bradley WP; Chretien PB
    Cancer Res; 1979 Feb; 39(2 Pt 1):542-4. PubMed ID: 83910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of p53 autoantibodies in sera from glioma patients.
    Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
    Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific cellular immune responses in patients with malignant gliomas.
    Sheikh KM; Apuzzo ML; Weiss MH
    Cancer Res; 1979 May; 39(5):1733-8. PubMed ID: 85487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum immunoglobulin (IgG, IgM, IgA) levels in patients with primary brain tumors (author's transl)].
    Nakao S; Terano M; Yamashita J; Handa H
    No To Shinkei; 1977 Sep; 29(9):1005-9. PubMed ID: 921855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating immune complexes in patients with nasopharyngeal carcinoma.
    Wolf GT; Wolfe RA
    Laryngoscope; 1990 Mar; 100(3):302-8. PubMed ID: 1689798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Soluble class HLA antigens in serum of patients with brain tumors].
    Turowski G; Gościński I; Gieracka D; Kedzierska A; Pawłowska E; Danilewicz B
    Pol Merkur Lekarski; 1996 Dec; 1(6):410-1. PubMed ID: 9273234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses in patients with gliomas.
    Brooks WH; Caldwell HD; Mortara RH
    Surg Neurol; 1974 Nov; 2(6):419-23. PubMed ID: 4372736
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of the protein profile of the Adélé tribe of Togo].
    Tété-Bénissan AC; Duriez P; Parra HJ
    Sante; 2000; 10(4):261-6. PubMed ID: 11111244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Humoral and cellular immunity in patients with left- and right-sided intracerebral tumors].
    Lisianyĭ NI; Markova OV; Prikhodchenko IA; Primushko LI
    Zh Vopr Neirokhir Im N N Burdenko; 1989; (2):33-5. PubMed ID: 2787570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual serum proteins and acute phase reactants in monoclonal immunoglobulinopathies (a study in patients with IgG myeloma).
    Wiedermann D; Widermann B; Cídl K; Kodousková V
    Neoplasma; 1978; 25(2):189-96. PubMed ID: 643123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aluminum concentrations in serum of patients with intracranial tumors.
    Philipov P; Tzatchev K
    Zentralbl Neurochir; 1993; 54(3):148-50. PubMed ID: 8237170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of smoking and age on serum levels of immune-reactive proteins altered in cancer patients.
    Weiss JF; Wolf GT; Edwards BK; Chretien PB
    Cancer Detect Prev; 1981; 4(1-4):211-7. PubMed ID: 6984657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum immunoglobulin and acute phase protein concentrations in pulmonary tuberculosis patients in Singapore.
    Wong CT; Saha N
    Trop Geogr Med; 1989 Jul; 41(3):218-21. PubMed ID: 2480678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The features of the brain immune system in brain neoplasms].
    Starchenko AA; Khil'ko VA; Komarets SA; Shulev IuA; Ivanteeva EP; Bikmullin VN; Prilukova TI
    Zh Vopr Neirokhir Im N N Burdenko; 2002; (4):22-6; discussion 26-7. PubMed ID: 12608143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of changes in serum proteins, immunoglobulins, and autoantibodies in leprosy.
    Rawlinson WD; Basten A; Hargrave JC
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):277-85. PubMed ID: 2439620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunological study of glioma. (2) Changes of immunological responses during treatment].
    Sobue H; Tanimura K; Terabayashi T; Minagawa M; Inoue K
    No To Shinkei; 1976 Jan; 28(1):87-93. PubMed ID: 194609
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunoregulatory cell function in peripheral blood leukocytes of patients with intracranial gliomas.
    Braun DP; Penn RD; Flannery AM; Harris JE
    Neurosurgery; 1982 Feb; 10(2):203-9. PubMed ID: 6280097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics and immunologic changes in patients with malignant brain tumors].
    Khonina NA; Tsentner MI; Leplina OIu; Tikhonova MA; Stupak VV; Nikonov SD; Chërnykh ER; Ostanin AA
    Vopr Onkol; 2002; 48(2):196-201. PubMed ID: 12227068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antigen-specific immunotherapy as a component of combined therapy for malignant brain tumors].
    Ostanin AA; Tsentner MI; Khonina NA; Leplina OIu; Shevela EIa; Nikonov SD; Stupak VV; Chërnykh ER
    Vopr Onkol; 2003; 49(2):170-5. PubMed ID: 12785199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma.
    Rempel SA; Dudas S; Ge S; Gutiérrez JA
    Clin Cancer Res; 2000 Jan; 6(1):102-11. PubMed ID: 10656438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.